Point72 Asset Management, L.P. 13D/13G Filings for LENZ Therapeutics, Inc. (LENZ)

Point72 Asset Management, L.P. 13D and 13G filings for LENZ Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-03-25
4:33 pm
Purchase
2024-03-2113GLENZ Therapeutics, Inc.
LENZ
Point72 Asset Management, L.P.1,882,693
7.400%
1,882,693increase
(New Position)
Filing